Skip to main content
Top
Published in: Lung 1/2014

01-02-2014

Lung Cysts as Indicator for Birt–Hogg–Dubé Syndrome

Authors: P. C. Johannesma, E. Thunnissen, P. E. Postmus

Published in: Lung | Issue 1/2014

Login to get access

Abstract

In this case, we describe a patient with a history of recurrent pneumothorax. Based on CT-thorax and histopathology of the lung tissue, the Birt–Hogg–Dubé syndrome was suspected and confirmed after genetic testing. Recognizing this syndrome by pulmonologists and radiologists is very important, because the risk on developing of renal cell cancer is high.
Literature
1.
go back to reference Furuya M, Tanaka R, Koga S et al (2012) Pulmonary cysts of Birt-Hogg-Dubé syndrome: a clinicopathologic and Immunohistochemical study of 9 families. Am J Surg Pathol 36:589–600CrossRefPubMed Furuya M, Tanaka R, Koga S et al (2012) Pulmonary cysts of Birt-Hogg-Dubé syndrome: a clinicopathologic and Immunohistochemical study of 9 families. Am J Surg Pathol 36:589–600CrossRefPubMed
2.
go back to reference Menko FH, van Steensel MAM, Giraud S et al (2009) Birt–Hogg–Dubé syndrome: diagnosis and management. Lancet Oncol 10:1199–1206CrossRefPubMed Menko FH, van Steensel MAM, Giraud S et al (2009) Birt–Hogg–Dubé syndrome: diagnosis and management. Lancet Oncol 10:1199–1206CrossRefPubMed
Metadata
Title
Lung Cysts as Indicator for Birt–Hogg–Dubé Syndrome
Authors
P. C. Johannesma
E. Thunnissen
P. E. Postmus
Publication date
01-02-2014
Publisher
Springer US
Published in
Lung / Issue 1/2014
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-013-9522-0

Other articles of this Issue 1/2014

Lung 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine